These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 22408438)
1. ACVR1, a therapeutic target of fibrodysplasia ossificans progressiva, is negatively regulated by miR-148a. Song H; Wang Q; Wen J; Liu S; Gao X; Cheng J; Zhang D Int J Mol Sci; 2012; 13(2):2063-2077. PubMed ID: 22408438 [TBL] [Abstract][Full Text] [Related]
2. The ACVR1 R206H mutation found in fibrodysplasia ossificans progressiva increases human induced pluripotent stem cell-derived endothelial cell formation and collagen production through BMP-mediated SMAD1/5/8 signaling. Barruet E; Morales BM; Lwin W; White MP; Theodoris CV; Kim H; Urrutia A; Wong SA; Srivastava D; Hsiao EC Stem Cell Res Ther; 2016 Aug; 7(1):115. PubMed ID: 27530160 [TBL] [Abstract][Full Text] [Related]
3. AAV-Mediated Targeting of the Activin A-ACVR1 Yang YS; Lin C; Ma H; Xie J; Kaplan FS; Gao G; Shim JH Biomolecules; 2023 Sep; 13(9):. PubMed ID: 37759764 [TBL] [Abstract][Full Text] [Related]
4. Classic and atypical fibrodysplasia ossificans progressiva (FOP) phenotypes are caused by mutations in the bone morphogenetic protein (BMP) type I receptor ACVR1. Kaplan FS; Xu M; Seemann P; Connor JM; Glaser DL; Carroll L; Delai P; Fastnacht-Urban E; Forman SJ; Gillessen-Kaesbach G; Hoover-Fong J; Köster B; Pauli RM; Reardon W; Zaidi SA; Zasloff M; Morhart R; Mundlos S; Groppe J; Shore EM Hum Mutat; 2009 Mar; 30(3):379-90. PubMed ID: 19085907 [TBL] [Abstract][Full Text] [Related]
5. BMP signaling and skeletal development in fibrodysplasia ossificans progressiva (FOP). Towler OW; Shore EM Dev Dyn; 2022 Jan; 251(1):164-177. PubMed ID: 34133058 [TBL] [Abstract][Full Text] [Related]
6. Reduced GS Domain Serine/Threonine Requirements of Fibrodysplasia Ossificans Progressiva Mutant Type I BMP Receptor ACVR1 in the Zebrafish. Allen RS; Jones WD; Hale M; Warder BN; Shore EM; Mullins MC J Bone Miner Res; 2023 Sep; 38(9):1364-1385. PubMed ID: 37329499 [TBL] [Abstract][Full Text] [Related]
7. Fibrodysplasia ossificans progressiva mutant ACVR1 signals by multiple modalities in the developing zebrafish. Allen RS; Tajer B; Shore EM; Mullins MC Elife; 2020 Sep; 9():. PubMed ID: 32897189 [TBL] [Abstract][Full Text] [Related]
8. Molecular consequences of the ACVR1(R206H) mutation of fibrodysplasia ossificans progressiva. Song GA; Kim HJ; Woo KM; Baek JH; Kim GS; Choi JY; Ryoo HM J Biol Chem; 2010 Jul; 285(29):22542-53. PubMed ID: 20463014 [TBL] [Abstract][Full Text] [Related]
9. A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva. Shore EM; Xu M; Feldman GJ; Fenstermacher DA; Cho TJ; Choi IH; Connor JM; Delai P; Glaser DL; LeMerrer M; Morhart R; Rogers JG; Smith R; Triffitt JT; Urtizberea JA; Zasloff M; Brown MA; Kaplan FS Nat Genet; 2006 May; 38(5):525-7. PubMed ID: 16642017 [TBL] [Abstract][Full Text] [Related]
10. Neofunction of ACVR1 in fibrodysplasia ossificans progressiva. Hino K; Ikeya M; Horigome K; Matsumoto Y; Ebise H; Nishio M; Sekiguchi K; Shibata M; Nagata S; Matsuda S; Toguchida J Proc Natl Acad Sci U S A; 2015 Dec; 112(50):15438-43. PubMed ID: 26621707 [TBL] [Abstract][Full Text] [Related]
11. [A Chinese girl with fibrodysplasia ossificans progressiva caused by a de novo mutation R206H in ACVR1 gene]. Zhou Q; Meng Y; Su L; Zhao SM; Shi HP; Huang SZ Zhonghua Er Ke Za Zhi; 2008 Mar; 46(3):215-9. PubMed ID: 19099712 [TBL] [Abstract][Full Text] [Related]
12. ACVR1 p.Q207E causes classic fibrodysplasia ossificans progressiva and is functionally distinct from the engineered constitutively active ACVR1 p.Q207D variant. Haupt J; Deichsel A; Stange K; Ast C; Bocciardi R; Ravazzolo R; Di Rocco M; Ferrari P; Landi A; Kaplan FS; Shore EM; Reissner C; Seemann P Hum Mol Genet; 2014 Oct; 23(20):5364-77. PubMed ID: 24852373 [TBL] [Abstract][Full Text] [Related]
13. Overexpression of Wild-Type ACVR1 in Fibrodysplasia Ossificans Progressiva Mice Rescues Perinatal Lethality and Inhibits Heterotopic Ossification. Yamamoto M; Stoessel SJ; Yamamoto S; Goldhamer DJ J Bone Miner Res; 2022 Nov; 37(11):2077-2093. PubMed ID: 35637634 [TBL] [Abstract][Full Text] [Related]
14. Variable signaling activity by FOP ACVR1 mutations. Haupt J; Xu M; Shore EM Bone; 2018 Apr; 109():232-240. PubMed ID: 29097342 [TBL] [Abstract][Full Text] [Related]
15. ACVR1R206H receptor mutation causes fibrodysplasia ossificans progressiva by imparting responsiveness to activin A. Hatsell SJ; Idone V; Wolken DM; Huang L; Kim HJ; Wang L; Wen X; Nannuru KC; Jimenez J; Xie L; Das N; Makhoul G; Chernomorsky R; D'Ambrosio D; Corpina RA; Schoenherr CJ; Feeley K; Yu PB; Yancopoulos GD; Murphy AJ; Economides AN Sci Transl Med; 2015 Sep; 7(303):303ra137. PubMed ID: 26333933 [TBL] [Abstract][Full Text] [Related]
17. Allele-Selective LNA Gapmers for the Treatment of Fibrodysplasia Ossificans Progressiva Knock Down the Pathogenic ACVR1 Maruyama R; Nguyen Q; Roshmi RR; Touznik A; Yokota T Nucleic Acid Ther; 2022 Jun; 32(3):185-193. PubMed ID: 35085461 [TBL] [Abstract][Full Text] [Related]
18. The obligatory role of Activin A in the formation of heterotopic bone in Fibrodysplasia Ossificans Progressiva. Alessi Wolken DM; Idone V; Hatsell SJ; Yu PB; Economides AN Bone; 2018 Apr; 109():210-217. PubMed ID: 28629737 [TBL] [Abstract][Full Text] [Related]
19. Dysregulated BMP signaling through ACVR1 impairs digit joint development in fibrodysplasia ossificans progressiva (FOP). Towler OW; Peck SH; Kaplan FS; Shore EM Dev Biol; 2021 Feb; 470():136-146. PubMed ID: 33217406 [TBL] [Abstract][Full Text] [Related]
20. A case of Fibrodysplasia Ossificans Progressiva associated with a novel variant of the ACVR1 gene. Cappato S; Traberg R; Gintautiene J; Zara F; Bocciardi R Mol Genet Genomic Med; 2021 Oct; 9(10):e1774. PubMed ID: 34347384 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]